LifeTech Capital Recommends NovaBay Pharmaceuticals
NovaBay of Emeryville, Calif., develops antimicrobial products for a variety of infections, including conjunctivitis, MRSA, the skin disease impetigo, and urinary tract infections.
utis
Cubist/Calixa Deal the Latest in a String of Biotech Buyouts
Cubist Pharmaceuticals has announced plans to acquire tiny San Diego biotech Calixa Therapeutics for up to $402.5 million.